Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Biomarkers in Medicine|May 19, 2010
Imaging biomarkers of atherosclerosisStéphane Noble, Therese Heinonen, Jean-Claude Tardif
Biomarkers in Cancer|June 4, 2016
The Role of Biomarkers in Decreasing Risk of Cardiac Toxicity after Cancer TherapyChristine Henri, Therese Heinonen, Jean-Claude Tardif
Current Atherosclerosis Reports|December 17, 2008
High-density lipoprotein/apolipoprotein A-I infusion therapyJean-Claude Tardif, Therese Heinonen, Stephane Noble
Circulation|June 28, 2006
Vascular biomarkers and surrogates in cardiovascular diseaseJean-Claude Tardif, Therese Heinonen, David Orloff, et al.
Clinical Pharmacokinetics|May 7, 2018
Clinical Pharmacokinetics and Pharmacodynamics of DalcetrapibDonald M Black, Darren Bentley, Sunny Chapel, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|December 19, 2006
Coronary vasodilator reserve and Framingham risk scores in subjects at risk for coronary artery diseaseSharmila Dorbala, Alita Hassan, Therese Heinonen, et al.
Journal of the American College of Cardiology|February 15, 2005
Quantitative relation between hemodynamic changes during intravenous adenosine infusion and the magnitude of coronary hyperemia: implications for myocardial perfusion imagingRakesh K Mishra, Sharmila Dorbala, Giridhar Logsetty, et al.
American Heart Journal|October 3, 2002
Design features of the Avasimibe and Progression of coronary Lesions assessed by intravascular UltraSound (A-PLUS) clinical trialJean-Claude Tardif, Jean Grégoire, Jacques Lespérance, et al.
The Journal of Thoracic and Cardiovascular Surgery|May 30, 2007
Effects of pyridoxal-5'-phosphate (MC-1) in patients undergoing high-risk coronary artery bypass surgery: results of the MEND-CABG randomized studyJean-Claude Tardif, Michel Carrier, David E Kandzari, et al.
Pageof 2